Table 3.
Mast-cell-mediated symptoms and signs
| Symptoms and signs | Total (n=66) n (%) | MPCM (n=44) n (%) | DCM (n=2) n (%) | MOS (n=19) n (%) | SM (n=1) n (%) |
|---|---|---|---|---|---|
| Itching | 49 (74.2) | 32 (48.4) | 2 (100) | 14 (73.6) | 1 (100) |
| Recurrent abdominal pain | 6 (9.1) | 5 (11.3) | 0 | 1 (5.2) | 0 |
| Diarrhea | 2 (3.0) | 1 (2.2) | 0 | 1 (5.2) | 0 |
| Headache, dizziness | 1 (1.5) | 0 | 0 | 0 | 1 (100) |
| Dyspnea | 3 (4.5) | 3 (6.8) | 0 | 0 | 0 |
| Cough, recurrent sinopulmonary infections | 1 (1.5) | 1 (2.2) | 0 | 0 | 0 |
| Angioedema | 1 (1.5) | 0 | 0 | 0 | 1 (100) |
| Blistering of skin | 29 (43.9) | 14 (31.8) | 2 (100) | 12 (63.1) | 1 (100) |
| Darier sign | 47 (71.2) | 28 (63.6) | 2 (100) | 16 (84.2) | 1 (100) |
*Systemic symptoms were reported in 12 patients of whom two had more than one systemic symptom.